glp-1 journal GLP-1-based therapies for diabetes, obesity and beyond The Story of GLP-1

Are you on a GLP-1? Studies show up to 40% of weight lost on GLP-1 medications may come from lean body mass, including muscle

As science continues to uncover how GLP-1 receptor agonists interact with the brains reward circuits, new possibilities are emerging

Insurance plans place GLP-1 drugs into different coverage tiers, often requiring prior authorization or high out-of-pocket costs

Learn how GLP-1 medications like Ozempic, Wegovy, and Zepbound may impact lymphedema, weight loss, swelling, inflammation, and patient outcomes

Now it's in magazine headlines, late-night monologues, and half the

Outline of the University of Iowa Neuroendocrine Tumor SPORE in Human Cancer